R

Monoclonal Antibody Treatments for Alzheimer's: the Good, the Bad, and the Difficult

By Robert Przybelski
403 views
January 30, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
19:54
Anton Porsteinsson

Aducanumab FDA Approval for Alzheimer's Disease: The Importance…

57:45
ACHL

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

Feat. J. Galvin
35:24
University of Miami

Lewy Body Dementia: The Most Common Disease You Never Heard Of

Feat. J. Galvin
41:59
ZINCARE

Approach to Cognitive Impairment in Adults

Feat. M. Mataa
30:25
ZINCARE

Cognitive Disorders

Feat. M. Mataa
26:51
2023 Conference Coverage

Updates in Dementia

Feat. P. Tipton
34:59
Lawrence Robbins

Alzheimer's: Clinical Pearls

58:23
Alberto Espay

The Illusion of Progress: Lecanemab in Alzheimer's Disease

11:38
Marc Cohen

The Association Between Herpes Simplex Virus and Alzheimer's Di…

Feat. J. Jagdeo
18:20
The National Dementias Conference

BPSD in Alzheimer's: An Update of Evidence

Feat. B. Underwood
29:39
Houston Methodist Hospital

Plasma Biomarkers in the Clinic and Clinical Trials

Feat. C. Teunissen
16:01
AD/PD™ International Conference

Cellular Senescence As A Pathogenic Contributor And Therapeutic Targ…

Feat. M. E. Orr
31:28
University of Miami

Alzheimer’s Disease Variants & Mimics

Feat. D. O'Shea
36:43
AdventHealth

Considerations and Use of Blood-Based Biomarkers for a Clinical Cogn…

Feat. M. M. Mielke
13:53
Jeffrey Cummings

Aducanumab Clinical Application: Patient Selection, Titration, and S…

20:14
Banner Alzheimer's Institute

Alzheimer's and Related Dementias: Definitions, Epidemiology, a…

Feat. G. Gopalakrishna
48:14
Scripps Health

Alzheimer's Dementia Updates

Feat. N. Hwynn
15:16
Campaign to Prevent Alzheimer's disease (PAD 2020)

Diagnosing Dementia

Feat. S. E. Schindler, J. Weiss
24:01
Banner Alzheimer's Institute

Diagnostic Evaluation of Suspected Dementia

Feat. G. Gopalakrishna
40:16
Bruce L. Miller

bvFTD: The Clinical Syndrome